Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000374031

Medchemexpress LLC Baricitinib-d3 | 1564242-30-3 | C16H14D3N7O2S | 1 MG
SDP

Catalog No. 5000374031
Encompass_Preferred

Baricitinib-d3 is the deuterium labeled version of Baricitinib, a selective and orally bioavailable JAK1 and JAK2 inhibitor with IC50s of 5.9 nM and 5.7 nM, respectively. It is intended for research use only.

  • Deuterium labeled Baricitinib
  • Selective and orally bioavailable JAK1 and JAK2 inhibitor
  • Suitable as a tracer
  • Functions as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS
  • Incorporates stable heavy isotopes for quantitation during drug development
  • Deuteration can impact pharmacokinetic and metabolic profiles of drugs

Catalog No. 50-003-74031 Supplier Medchemexpress LLC Supplier No. HY15315S11MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Baricitinib-d3 is the deuterium labeled version of Baricitinib, a selective and orally bioavailable JAK1 and JAK2 inhibitor with IC50s of 5.9 nM and 5.7 nM, respectively. It is intended for research use only.

  • Deuterium labeled Baricitinib
  • Selective and orally bioavailable JAK1 and JAK2 inhibitor
  • Suitable as a tracer
  • Functions as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS
  • Incorporates stable heavy isotopes for quantitation during drug development
  • Deuteration can impact pharmacokinetic and metabolic profiles of drugs

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.